Therapeutic effect of repetitive transcranial magnetic stimulation in PD
Shimamoto H, Morimitsu H, Sugita S, Nakahara K,
Rinsho Shinkeigaku. 1999 Dec;39(12):1264-7.
PMID: 10791094; UI: 20251690

Molecular mechanism of monoamine toxicity in PD
Jimenez del Rio M, Velez-Pardo C.
Med Hypotheses. 2000 Feb;54(2):269-74.
PMID: 10790763; UI: 20253830

The toxic mind: the biology of mental illness and violence.
Van Winkle E.
Med Hypotheses. 2000 Jan;54(1):146-56.
PMID: 10790741; UI: 20250365

New animal models for Parkinson's disease.
Dawson TM.
Cell. 2000 Apr 14;101(2):115-8. Review. No abstract available.
PMID: 10786830; UI: 20246502

Pharmaceutical target discovery: PD and schizophrenia genes.
Walker MG, Volkmuth W, Klingler TM.
Ismb. 1999;:282-6.
PMID: 10786311; UI: 20248035

Cardiovascular autonomic dysfunction in PD
Mathias CJ.
Clin Neurosci. 1998;5(2):153-66. Review.
PMID: 10785842; UI: 20247548

Visuo-cognitive dysfunctions in PD
Antal A, Bandini F, Keri S, Bodis-Wollner I.
Clin Neurosci. 1998;5(2):147-52. Review.
PMID: 10785841; UI: 20247547

Gastrointestinal dysfunction in PD
Pfeiffer RF.
Clin Neurosci. 1998;5(2):136-46. Review.
PMID: 10785840; UI: 20247546

Respiratory function in PD
Shill H, Stacy M.
Clin Neurosci. 1998;5(2):131-5. Review.
PMID: 10785839; UI: 20247545

Neurophysiology of sensorimotor integration in PD
Rossini PM, Filippi MM, Vernieri F.
Clin Neurosci. 1998;5(2):121-30. Review.
PMID: 10785838; UI: 20247544

Imaging of nonmotor symptoms in Parkinson syndromes.
Paulus W, Trenkwalder C.
Clin Neurosci. 1998;5(2):115-20. Review.
PMID: 10785837; UI: 20247543

Sleep dysfunction in PD
Trenkwalder C.
Clin Neurosci. 1998;5(2):107-14. Review.
PMID: 10785836; UI: 20247542

Visual dysfunction in PD
Rodnitzky RL.
Clin Neurosci. 1998;5(2):102-6. Review.
PMID: 10785835; UI: 20247541

Olfactory dysfunction in PD
Wszolek ZK, Markopoulou K.
Clin Neurosci. 1998;5(2):94-101. Review.
PMID: 10785834; UI: 20247540

Behavioral dysfunction in PD
Friedman JH.
Clin Neurosci. 1998;5(2):87-93. Review.
PMID: 10785833; UI: 20247539

Urinary dysfunction in PD
Singer C.
Clin Neurosci. 1998;5(2):78-86. Review.
PMID: 10785832; UI: 20247538

Sexual dysfunction in PD
Lambert D, Waters CH.
Clin Neurosci. 1998;5(2):73-7. Review.
PMID: 10785831; UI: 20247537

Pain in PD
Ford B.
Clin Neurosci. 1998;5(2):63-72. Review.
PMID: 10785830; UI: 20247536

CP-101,606, an Antagonist of NR2B Subunit-Containing N-Methyl-d-Aspartate Receptors.
Steece-Collier K, Chambers LK, Jaw-Tsai SS, Menniti FS,
Exp Neurol. 2000 May;163(1):239-243.
PMID: 10785463

125I-CGP 64213 Binding to GABA(B) Receptors in the Brain of Monkeys
Calon F, Morissette M, Goulet M, Grondin R,
Exp Neurol. 2000 May;163(1):191-199.
PMID: 10785458

GDNF and NT-4 Protect Dopaminergic Neurons from Damage by Iron and Nitric Oxide.
Lingor P, Unsicker K, Krieglstein K.
Exp Neurol. 2000 May;163(1):55-62.
PMID: 10785444

An Altered Histaminergic Innervation of the Substantia Nigra in PD
Anichtchik OV, Rinne JO, Kalimo H, Panula P.
Exp Neurol. 2000 May;163(1):20-30.
PMID: 10785440

PD impairs the ability to change set quickly.
Chong RK, Horak FB, Woollacott MH.
J Neurol Sci. 2000 Apr 1;175(1):57-70.
PMID: 10785258

Early differentiation of PD and MSA with I-123-MIBG-SPECT.
Druschky A, Hilz MJ, Platsch G, Radespiel-Troger M,
J Neurol Sci. 2000 Apr 1;175(1):3-12.
PMID: 10785250

VIP relevance to neuroprotection in PD
Offen D, Sherki Y, Melamed E, Fridkin M,
Brain Res. 2000 Jan 31;854(1-2):257-62.
PMID: 10784133; UI: 20244719

GDNF and increased survival of dopaminergic neurons in fetal grafts
Espejo M, Cutillas B, Arenas TE, Ambrosio S.
Cell Transplant. 2000 Jan-Feb;9(1):45-53.
PMID: 10784066; UI: 20244652

Effect of swallowing training on swallowing disorders in PD
Nagaya M, Kachi T, Yamada T.
Scand J Rehabil Med. 2000 Mar;32(1):11-5.
PMID: 10782935; UI: 20243029

Structural changes in substantia nigra in PD revealed by MR imaging.
Hutchinson M, Raff U.
AJNR Am J Neuroradiol. 2000 Apr;21(4):697-701.
PMID: 10782780; UI: 20242874

Effects of L-DOPA and the D1 agonist SKF 82958 in monkey model.
Andringa G, Lubbers L, Drukarch B, Stoof JC,
Behav Pharmacol. 1999 Mar;10(2):175-82.
PMID: 10780830; UI: 20241742

Effects of D2 agonist quinpirole and D1 agonist SKF 81297 in monkey model.
Andringa G, Vermeulen RJ, Drukarch B, Renier WO,
Behav Pharmacol. 1999 Mar;10(2):163-73.
PMID: 10780829; UI: 20241741

COMT inhibition in PD: rationale and clinical relevance.
Deleu D.
Acta Neurol Belg. 2000 Mar;100(1):5-7. No abstract available.
PMID: 10779856; UI: 20242128

Parkinsonian Motor Characteristics in Unipolar Major Depression.
Rogers MA, Bradshaw JL, Phillips JG, Chiu E,
J Clin Exp Neuropsychol. 2000 Apr;22(2):232-244.
PMID: 10779837

Effect of selegiline on cognitive functions in PD
Dixit SN, Behari M, Ahuja GK.
J Assoc Physicians India. 1999 Aug;47(8):784-6.
PMID: 10778622; UI: 20241090

Rejection of Porcine Mesencephalic Xenografts in a Rat Model of PD
Barker RA, Ratcliffe E, McLaughlin M, Richards A,
J Neurosci. 2000 May 1;20(9):3415-3424.
PMID: 10777804

Sleep attacks and PD treatment.
Ferreira JJ, Galitzky M, Montastruc JL, Rascol O.
Lancet. 2000 Apr 15;355(9212):1333-4.
PMID: 10776750; UI: 20236508

Sleep attacks (sleep episodes) with pergolide.
Schapira AH.
Lancet. 2000 Apr 15;355(9212):1332-3.
PMID: 10776749; UI: 20236507

Abnormal reciprocal inhibition between antagonist muscles in PD
Meunier S, Pol S, Houeto JL, Vidailhet M.
Brain. 2000 May;123(Pt 5):1017-1026.
PMID: 10775546

The surgical treatment of PD
Follett KA.
Annu Rev Med. 2000;51:135-47.
PMID: 10774457; UI: 20236272

Repetitive transcranial magnetic stimulation in PD
Siebner HR, Mentschel C, Auer C, Lehner C,
Neurosci Lett. 2000 Apr 28;284(3):147-50.
PMID: 10773420; UI: 20237803

Naloxone Protects Rat Dopaminergic Neurons against Inflammatory Damage
Liu B, Du L, Hong JS.
J Pharmacol Exp Ther. 2000 May 1;293(2):607-617.
PMID: 10773035

Metabolic activity in the subthalamic nucleus in a rat model of PD
Orieux G, Francois C, Feger J, Yelnik J,
Neuroscience. 2000;97(1):79-88.
PMID: 10771341; UI: 20235584

Nicotinic receptors and PD
Quik M, Jeyarasasingam G.
Eur J Pharmacol. 2000 Mar 30;393(1-3):223-30.
PMID: 10771017; UI: 20235313

Functional brain imaging of movement disorders.
Eidelberg D, Edwards C.
Neurol Res. 2000 Apr;22(3):305-12.
PMID: 10769825; UI: 20232658

Mechanisms of deep brain stimulation and future technical developments.
Montgomery EB Jr, Baker KB.
Neurol Res. 2000 Apr;22(3):259-66.
PMID: 10769818; UI: 20232651

Advances in neurostimulation for movement disorders.
Gross RE, Lozano AM.
Neurol Res. 2000 Apr;22(3):247-58.
PMID: 10769817; UI: 20232650

Future prospects of brain stimulation.
Benabid AL, Koudsie A, Pollak P, Kahane P,
Neurol Res. 2000 Apr;22(3):237-46.
PMID: 10769816; UI: 20232649

Parkinson disease survival: a population-based study.
Morgante L, Salemi G, Meneghini F, Di Rosa AE,
Arch Neurol. 2000 Apr;57(4):507-12.
PMID: 10768625; UI: 20229112

The alpha-synuclein gene and PD in a Chinese population.
Chan DK, Mellick G, Cai H, Wang XL,
Arch Neurol. 2000 Apr;57(4):501-3.
PMID: 10768624; UI: 20229111

Cognitive impairment and the brain dopaminergic system in PD
Rinne JO, Portin R, Ruottinen H, Nurmi E,
Arch Neurol. 2000 Apr;57(4):470-5.
PMID: 10768619; UI: 20229106

Subthalamic stimulation in PD: a multidisciplinary approach.
Houeto JL, Damier P, Bejjani PB, Staedler C,
Arch Neurol. 2000 Apr;57(4):461-5.
PMID: 10768618; UI: 20229105

PET: the merging of biology and imaging into molecular imaging.
Phelps ME.
J Nucl Med. 2000 Apr;41(4):661-81. Review.
PMID: 10768568; UI: 20229055

Binding of [99mTc]TRODAT-1 to dopamine transporters in PD
Mozley PD, Schneider JS, Acton PD, Plossl K,
J Nucl Med. 2000 Apr;41(4):584-9.
PMID: 10768556; UI: 20229043


janet paterson
53 now / 41 dx / 37 onset
613 256 8340 / PO Box 171 Almonte Ontario K0A 1A0 Canada
visit my website "a new voice" at: http://www.geocities.com/janet313/